Ultrahuman Peak female test
The Peak Performance (Female) blood testing panel is built by Ultrahuman for a comprehensive, gold-standard understanding of your blood markers. Unique markers like AMH and Prolactin support a deeper understanding of your body’s functioning. It also includes biomarkers across disease risk insights, glucose regulation, lipid profile, inflammation, hormone balance, muscle health, thyroid health, micronutrient status, and more.
Book your blood draw with Valeo, then upload your report to the Ultrahuman app.
Health Coach to review biomarkers + Ultrahuman trends
DHA-licensed nurses & lab partners
Avoid intense exercise for 24 hours before your blood draw
10 hours fasting required prior to testing
Results in 3 to 5 days
80+ Biomarkers Mapped to Ultrahuman Peak Performance (Female)
This test is mapped to Ultrahuman’s Peak Performance (Female) blood panel for a comprehensive, gold-standard view of your blood markers. Unique markers like AMH and Prolactin support a deeper understanding of your body’s functioning. It also includes biomarkers across disease risk insights, glucose regulation, lipid profile, inflammation, hormone balance, muscle health, thyroid health, micronutrient status, and more. When paired with the ultrahuman ring, you can track your daily activity and biometric trends alongside these blood markers for a more complete view of your health.
Understanding your blood test results has never been this easy & convenient
Why Valeo
Accredited Laboratories
Our partner laboratories are CAP accredited and maintain the highest laboratory proficiency, quality standards, and certifications.
Science Backed
With a team of highly qualified experts, the latest scientific research, and the power of technology, we're committed to bringing you the best evidence based wellbeing advice.
Secure Data
We comply with the highest professional standards for data storage and protection so your personal information remains safe and confidential at all times. Check out our full privacy policy for more details.
